Coming in May to Vienna: Prostate Cancer Theranostics

Last year’s sold out course on Prostate Cancer Theranostics is coming back to Vienna! What knowledge can you expect to gain?

• PSMA PET-CT imaging- science and practice
  • To provide an overview of clinical applications, normal biodistribution, variants, pitfalls and artefacts in PSMA PET-CT
  • To learn how to report PSMA PET-CT scans in a structured manner
• Radionuclide PSMA therapy-science and practice (177Lu-PSMA and 225Ac-PSMA therapies)
  • To gain knowledge on PSMA-based patients selection when planning radionuclide therapies
  • To become familiar with common clinical challenges and side effects management, when implementing and delivering radionuclide therapies
  • To discuss current evidence and trends related to ¹⁷⁷Lu-PSMA and ²²⁵Ac-PSMA therapies
  • To learn about new or emerging targets and radioisotopes for Prostate cancer management.

Find the preliminary programme here.